• OPEN AN ACCOUNT
Indian Indices
Sensex
74,519.17 -262.59
( -0.35%)
Global Indices
Nasdaq
52,442.46 -151.83
(-0.29%)
Dow Jones
7,640.91 -37.07
(-0.48%)
Hang Seng
63,634.18 141.19
(0.22%)
Nikkei 225
10,692.77 42.33
(0.40%)
Forex
USD-INR
95.47 0.03
(0.03%)
EUR-INR
110.72 -0.23
(-0.20%)
GBP-INR
129.12 -0.04
(-0.03%)
JPY-INR
0.62 0.00
(0.29%)

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
539523
INE540L01014
1170.8077615
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ALKEM
27.15
60852.61
EPS(TTM)
Face Value()
Div & Yield %
187.45
2
1.04
 

Swarna Securities standalone net profit declines 84.21% in the March 2026 quarter
Jun 01,2026
Net profit of Swarna Securities declined 84.21% to Rs 0.03 crore in the quarter ended March 2026 as against Rs 0.19 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit declined 23.46% to Rs 0.62 crore in the year ended March 2026 as against Rs 0.81 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.